β2AR as a target in methamphetamine addiction: Divergent mechanisms from TAAR1
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.116337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Yize Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Synthetic Biology, Haihe Laboratory of Sustainable Chemical Transformations, Tianjin Key Laboratory of Function and Applicati…. Hauptthemen laut MEDLINE: Methamphetamine, Receptors, Adrenergic, beta-2, Receptors, G-Protein-Coupled, Amphetamine-Related Disorders. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Science Fund for Distinguished Young Scholars of Hubei Province, Ministry of Science and Technology of the People's Republic of China, Tianjin University.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Methamphetamine (METH) abuse poses a growing global health crisis, yet the molecular mechanisms underlying its addictive effects remain poorly understood. While METH is an established agonist of trace amine-associated receptor 1 (TAAR1), our study indicates β2-adrenergic receptor (β2AR) as a METH target, demonstrating its role in Gs-mediated cAMP signaling. Using cryo-electron microscopy and mutagenesis studies, we reveal the structural basis for METH's differential ligand efficacies and stereoselectivity at β2AR and TAAR1. We further investigated synaptic plasticity of medium spiny neurons (MSNs) in the nucleus accumbens (NAc), a key neural substrate for reward learning, and demonstrate that β2AR inhibition via the selective antagonist zenidolol elevates GluA1-Ser831 phosphorylation and augments excitatory inputs onto D2-MSNs in the NAc shell. In contrast, TAAR1 activation fails to elicit these synaptic modifications. Taken together, structural, behavioral, and synaptic plasticity findings highlight β2AR as a pivotal mediator of METH addiction, providing a framework for targeted therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Synthetic Biology, Haihe Laboratory of Sustainable Chemical Transformations, Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, Faculty of Medicine, Schoo…
- National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence Research, Peking University, Beijing 100191, China.
- State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hu…
- National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence Research, Peking University, Beijing 100191, China. Electronic address: shijie@bjmu.edu.cn.
Förderung
- Science Fund for Distinguished Young Scholars of Hubei Province
- Ministry of Science and Technology of the People's Republic of China
- Tianjin University
- Ministry of Science and Technology, Israel
- National Natural Science Foundation of China
Zitieren
APA
Wang, Y., Zhang, L., Li, J., Lin, Y., Yuwen, T., Wang, J., Zhang, K., Shi, J., Ye, S., Wu, S., & Qiao, A. (2025). β2AR as a target in methamphetamine addiction: Divergent mechanisms from TAAR1. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116337
Vancouver
Wang Y, Zhang L, Li J, Lin Y, Yuwen T, Wang J, et al. β2AR as a target in methamphetamine addiction: Divergent mechanisms from TAAR1. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116337
BibTeX
@article{Wang2025,
author = {Wang, Yize and Zhang, Libo and Li, Jie and Lin, Yun and Yuwen, Ting and Wang, Jiening and Zhang, Kexin and Shi, Jie and Ye, Sheng and Wu, Shan and Qiao, Anna},
title = {β2AR as a target in methamphetamine addiction: Divergent mechanisms from TAAR1},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.116337}
}
EUVIMED